2) convertible premium rate
转股溢价率
1.
To the convertible rate, the important attribute, this paper establishes the decision model and stresses the relation between the convertible rate and the convertible premium rate.
针对可转债的重 要属性转股率,建立转股率决定模型,重点分析了转股率与转股溢价率之间的关系。
3) Equity Premium
股权溢价
1.
The Risk-free Rate Puzzle and Equity Premium in China;
略论中国无风险利率与股权溢价
2.
Equity premium is a popular financial topic, its research concentrates on two aspects: one is to validate whether equity premium really exists, the other is to explain equity premium from different angles.
股权溢价问题是金融界一个比较热门的话题,研究的热点主要集中在两个方面:一是验证股权溢价之谜是否真实存在,二是从不同的角度对股权溢价之谜做出解释。
4) premium on holding interest
控股溢价
1.
From atheoretical perspective, mechanism of tender offer, namely therationality of premium on holding interest is probed into, whichresults in a brand new explanation of premium issue.
从理论角度探讨了要约收购出现的机理,即控股溢价在控股权转让中的合理性。
5) converting bonds over price
溢价转股
6) A-share price premium
A股溢价
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条